Table 2.
HR | CI | P-value | |
Male sex | 0.786 | 0.301-2.055 | 0.623 |
Age | 1.001 | 0.954-1.051 | 0.952 |
Aetiology of HCC | |||
Alcoholic liver disease | 0.523 | 0.175-1.567 | 0.247 |
Hepatitis C | 2.098 | 0.849-5.183 | 0.108 |
Haemochromatosis | 0.715 | 0.239-2.143 | 0.549 |
Other | 1.198 | 0.459-3.126 | 0.712 |
Pre-operative α-fetoprotein > 100 ng/mL | 1.502 | 0.437-5.165 | 0.519 |
Compliant with Milan criteria | 0.994 | 0.381-2.590 | 0.989 |
Compliant with UCSF criteria | 0.871 | 0.290-2.618 | 0.805 |
Largest lesion | 1.207 | 0.963-1.513 | 0.102 |
Cirrhosis | 23.309 | 0.024-224.813 | 0.369 |
Steatosis | 0.044 | 0.000-187.285 | 0.465 |
Multi-focal lesions | 1.201 | 0.499-2.890 | 0.683 |
Micro-vascular invasion | 1.489 | 0.619-3.578 | 0.374 |
Tumour differentiation | |||
Well | 0.862 | 0.349-2.131 | 0.748 |
Moderate | 1.100 | 0.448-2.698 | 0.835 |
Poor | 1.159 | 0.268-5.022 | 0.843 |
Incidental lesions | 0.450 | 0.060-3.391 | 0.438 |
HCC: Hepatocellular carcinoma; UCSF: University of California San Francisco.